Evaluating Perception of Clinical Trials within Multicultural Communities
1,2 1,2 1,2 3 3 Ethan Royka, BA , Nhi Nguyen, BA , Chase Shipp, BA , Phyu Niang, MD , Juliet Muir, MD , Manoj Ravichandran, 3 3 4 4 2,3 MD , Arsalan Boodhun, MD , Scott Jones, MS , Elizabeth Cohen, RN, PhD, FAAN and Daniel King, MD, PhD 1Northwell, New Hyde Park, NY, 2Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 3Institute of Cancer Research, Feinstein Institutes for
Medical Research, 4Northwell health, Institute of Health Systems Science
Results
Background • • • •
Table 1: Likert Scores by Demographic Group
Clinical trial participation is low among racial minorities Certain barriers have been identified, but the perceptions of diverse population is poorly understood These perceptions may prove insight into low clinical trial participation rates Queens, NY provides a unique research opportunity given its remarkable diversity.
Word Cloud of open-ended responses to the question :”What does the term ‘clinical trial’ mean to you?”
Hypothesis
•
Perceptions of clinical trial participation differ across racial, ethnic, and cultural groups, with values, language, and community networks shaping trust and willingness to enroll.
Methods • Setting: Queens Cancer Center • Approach: 20–30-minute surveys consisting of 46 questions (Likertscale+ open-ended) • Assess patient demographics, perceptions, and barriers • Analysis: includes descriptive stats, nonparametric tests, and topic modeling of open-test responses
Figure 1: Word Cloud of Patient’s Initial Perspectives on Clinical Trials
~19% of all patients could not provide a definition of a clinical trial
Future Direction • 1 Likert scores based on how important these factors are in one’s decision whether to not to
participate in a clinical trial. Shared Culture: How important is it to you that you and your doctor share the same culture?; Shared Language: How important is it to you that you and your doctor speak the same language?. Likert scores ranged from 1-5 with 1 being “Not Important at All” and 5 being “Very Important”. P-values produced from a Chi-squared test. Highlighted cells reflect statistically significant p-values (<.05).
Conclusions •
Some aspects of clinical trial perceptions differed significantly by race/ethnicity, income, and primary language while others were consistent cross all groups.
• •
Further research into why perceptions vary among ethnic groups Further data analysis using Latent Class Analysis and topic modeling (LDA) of open-text responses. Develop community-tailored education initiatives to improve awareness with the aid of local communities.
Resources Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14(9):537-46. DOI: 10.1046/j.1525-1497.1999.07048.x. Dreyfus B, Kuri L, Ferri M, et al. Understanding Hispanic/Latino Participation in Clinical Trials and Observational Studies, and Strategies to Increase Participation: A Targeted Literature Review. J Health Care Poor Underserved 2023;34(1):399-424. DOI: 10.1353/hpu.2023.0026. George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health 2014;104(2):e16-31. DOI: 10.2105/AJPH.2013.301706. Pittell H, Calip GS, Pierre A, et al. Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From2017 to 2022. JAMA Netw Open 2023;6(7):e2322515. DOI:10.1001/jamanetworkopen.2023.22515.